Interactive Chart for Abrdn Life Sciences Investors (HQL), analyze all the data with a huge range of indicators.

HQL offers a high 12% yield and trades at a discount, making it attractive for income-focused investors seeking healthcare sector exposure. The fund is heavily weighted in biotechnology, leading to ...

HQL offers a 14.2% dividend yield and diverse exposure to healthcare and life science companies. Since abrdn's acquisition in 2023, HQL has delivered a total return of 25.5%, though its price ...

Check out our HQL interactive chart to view the latest changes in value, key financial events & indicators, and compare abrdn Life Sciences Investors data across different funds and exchanges today.